サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1586367

デジタル治療市場、規模、シェア、動向、産業分析レポート：収益モデル別、用途別、エンドユーザー別、地域別 - 市場予測、2024年～2032年

Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model, Application, End Users, and Region - Market Forecast, 2024-2032

出版日
ページ情報
英文 116 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
デジタル治療市場、規模、シェア、動向、産業分析レポート：収益モデル別、用途別、エンドユーザー別、地域別 - 市場予測、2024年～2032年
出版日: 2024年10月01日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、デジタル治療市場規模は2032年までに706億3,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

デジタル治療市場の成長は、先進国だけでなく新興国市場でも世界的にインターネットアクセスが増加していることが原動力となっています。例えば、Our World in Dataの統計によると、2000年にはアジア人口の7%がインターネットにアクセスしていましたが、アフリカ地域ではわずか3%でした。2016年になると、インターネットにアクセスできる人口の割合は大幅に増加し、韓国と日本では人口の91％がインターネットにアクセスし、デンマークとノルウェーでは人口の97％がインターネットにアクセスしています。6年後の2022年には、アフリカの主要地域で81％の人口がインターネットにアクセスできるようになります。

エコシステム全体をデジタル化するための政府の取り組みやインセンティブが、予測期間中にデジタル治療市場を押し上げると予想されます。ヘルスケア部門における政府資金の増加とヘルスケア部門のデジタル化のためのスキームの導入は、調査期間中にデジタル治療市場を促進すると予想されています。例えば、2023年8月、インド政府は、デジタルヘルス、研究所、ヘルステック企業の採用を奨励するために、Ayushman Bharat Digital Mission（ABDM）の下でデジタルヘルスインセンティブスキーム（DHIS）を導入しました。デジタルヘルス奨励金制度では、新しいヘルステック新興企業に最高4兆インドルピーまでの奨励金が提供されます。

デジタル治療サービスの主な消費者は雇用者と患者です。大手企業は、従業員向けパッケージに治療サービスを追加し、生活習慣管理、うつ病、高血圧関連のサービスを提供し始めています。糖尿病や心血管疾患などの慢性疾患を抱える患者は、日々の相談にサービスを利用することができます。

デジタル治療市場レポートハイライト

収益モデル分析では、サブスクリプションセグメントが世界市場で大幅な成長を遂げると予測されています。この成長は、サブスクリプションベースの収益モデルに関連する主な利点に起因しています。

エンドユーザー別分析では、世界の主要企業がデジタル治療パッケージのサービスを開始したことから、2024年から2032年にかけて雇用者セグメントが市場を独占すると予測されます。

2023年、北米はインターネットにアクセスできる人口の割合が高く、デジタル化が進んでいるため、デジタル治療市場を独占しています。

インドのデジタル治療市場は、ヘルスケア分野のデジタル化に向けた規制支援やイニシアチブにより、大幅な成長が予測されています。

主な市場企業は、Proteus Digital Health, Inc.、Fitbit, Inc.、Pear Therapeutics, Inc.、Kaia Health、Happify, Inc.、Medtronic Plc.、Omada Health, Inc.、Livongo Health, Inc.、Voluntis Inc.、Resmed, Inc.、Welldoc, Inc.、2Morrow Inc.、Canary Health、Mindable Health GmbHなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のデジタル治療市場の洞察

  • 市場スナップショット
  • デジタル治療市場力学
    • 促進要因と機会
      • サービス指向ソフトウェアの進歩が市場の成長を牽引
      • インターネットに費やす日々の時間の増加が市場規模を押し上げている
    • 抑制要因と課題
      • 資本投資の不足
  • PESTEL分析
  • デジタル治療市場の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のデジタル治療市場：収益モデル別

  • 主な調査結果
  • イントロダクション
  • サブスクリプション
  • 価値ベース
  • 1回限りの購入

第6章 世界のデジタル治療市場：用途別

  • 主な調査結果
  • イントロダクション
  • 糖尿病
  • 肥満
  • 脳血管障害（CVD）
  • 中枢神経疾患
  • 呼吸器疾患
  • 禁煙
  • ライフスタイル管理
  • 予防用
  • その他

第7章 世界のデジタル治療市場：エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 患者
  • プロバイダー
  • 支払者
  • 雇用主
  • その他

第8章 世界のデジタル治療市場：地域別

  • 主な調査結果
  • イントロダクション
    • デジタル治療市場の評価：地域別、2019年～2032年
  • 北米
    • 北米：収益モデル別、2019年～2032年
    • 北米：用途別、2019年～2032年
    • 北米：エンドユーザー別、2019年～2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州：収益モデル別、2019年～2032年
    • 欧州：用途別、2019年～2032年
    • 欧州：エンドユーザー別、2019年～2032年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：収益モデル別、2019年～2032年
    • アジア太平洋地域：用途別、2019年～2032年
    • アジア太平洋地域：エンドユーザー別、2019年～2032年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：収益モデル別、2019年～2032年
    • 中東・アフリカ：用途別、2019年～2032年
    • 中東・アフリカ：エンドユーザー別、2019年～2032年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：収益モデル別、2019年～2032年
    • ラテンアメリカ：用途別、2019年～2032年
    • ラテンアメリカ：エンドユーザー別、2019年～2032年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Proteus Digital Health, Inc.
  • Fitbit Inc.
  • Pear Therapeutics, Inc.
  • Kaia Health
  • Happify, Inc.
  • Medtronic Plc.
  • Omada Health, Inc.
  • Livongo Health, Inc.
  • Voluntis, Inc.
  • Resmed, Inc.
  • Welldoc, Inc.
  • 2Morrow Inc.
  • Canary Health
  • Mindable Health GmbH.
図表

List of Tables:

  • Table 1 Global Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 2 Global Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 3 Global Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 4 North America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 5 North America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 6 North America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 7 U.S.: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 8 U.S.: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 9 U.S.: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 10 Canada: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 11 Canada: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 12 Canada: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 13 Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 14 Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 15 Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 16 UK: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 17 UK: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 18 UK: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 19 France: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 20 France: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 21 France: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 22 Germany: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 23 Germany: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 24 Germany: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 25 Italy: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 26 Italy: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 27 Italy: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 28 Spain: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 29 Spain: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 30 Spain: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 31 Netherlands: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 32 Netherlands: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 33 Netherlands: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 34 Russia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 35 Russia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 36 Russia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 37 Rest of Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 38 Rest of Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 39 Rest of Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 40 Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 41 Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 42 Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 43 China: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 44 China: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 45 China: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 46 India: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 47 India: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 48 India: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 49 Malaysia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 50 Malaysia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 51 Malaysia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 52 Japan: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 53 Japan: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 54 Japan: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 55 Indonesia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 56 Indonesia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 57 Indonesia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 58 South Korea: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 59 South Korea: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 60 South Korea: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 61 Australia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 62 Australia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 63 Australia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 64 Rest of Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 65 Rest of Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 66 Rest of Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 67 Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 68 Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 69 Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 70 Saudi Arabia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 71 Saudi Arabia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 72 Saudi Arabia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 73 UAE: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 74 UAE: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 75 UAE: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 76 Israel: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 77 Israel: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 78 Israel: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 79 South Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 80 South Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 81 South Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 82 Rest of Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 83 Rest of Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 84 Rest of Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 85 Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 86 Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 87 Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 88 Mexico: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 89 Mexico: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 90 Mexico: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 91 Brazil: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 92 Brazil: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 93 Brazil: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 94 Argentina: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 95 Argentina: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 96 Argentina: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • Table 97 Rest of Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • Table 98 Rest of Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • Table 99 Rest of Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)

List of Figures:

  • Figure 1. Global Digital Therapeutics Market, 2019-2032 (USD billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Revenue Model
  • Figure 7. Global Digital Therapeutics Market, by Revenue Model, 2023 & 2032 (USD billion)
  • Figure 8. Market by Application
  • Figure 9. Global Digital Therapeutics Market, by Application, 2023 & 2032 (USD billion)
  • Figure 10. Market by End User
  • Figure 11. Global Digital Therapeutics Market, by End User, 2023 & 2032 (USD billion)
  • Figure 12. Global Digital Therapeutics Market Assessment, By Geography, 2019-2032 (USD billion)
  • Figure 13. Strategic Analysis - Global Digital Therapeutics Market
目次
Product Code: PM1908

The digital therapeutics market size is expected to reach USD 70.63 billion by 2032, according to a new study by Polaris Market Research. The report "Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model (Subscription and Value-Based), Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The digital therapeutics market growth is driven by increasing internet access globally in developed as well as developing countries. For instance, according to statistics of Our World in Data, in 2000, 7% of the Asian population had access to the internet, while just 3% of the African region was online. By 2016, the population share with internet access increased significantly, with 91% of the population in South Korea and Japan having internet access and 97% of the population in Denmark and Norway online. After six years, in 2022, major regions of Africa witnessed 81% of the population share gain internet access.

Government initiatives and incentives in order to digitalize the whole ecosystem are anticipated to boost the digital therapeutics market during the forecast years. Increased government funding in the healthcare sector and the introduction of schemes for the digitalization of the healthcare sector are expected to fuel the digital therapeutics market during the study time. For instance, in August 2023, the government of India introduced the Digital Health Incentive Scheme (DHIS) under the Ayushman Bharat Digital Mission (ABDM) to encourage the adoption of digital health, laboratories, and health tech companies. In the digital health incentive scheme, new health tech startups will be offered incentives up to 4 crore INR.

Employers and patients are the major consumers of digital therapeutic services. Major companies have started adding therapies as services in their employee packages, providing lifestyle management, depression, and hypertension-related services. Patients with chronic diseases, such as diabetes and cardiovascular diseases, can use the services for day-to-day consultation.

Digital Therapeutics Market Report Highlights

By revenue model analysis, the subscription segment is anticipated to experience substantial growth in the global market. This growth is attributed to major advantages that are associated with the subscription-based revenue model.

By end users analysis, the employers segment is anticipated to dominate the market from 2024 to 2032 due to major companies globally having started including digital therapeutics packages in their services.

In 2023, North America dominated the digital therapeutics market due to the large share of the population having internet access and increasing digitalization.

The digital therapeutics market in India is projected for substantial growth due to the regulatory support and initiatives for the digitalization of the healthcare sector.

The key market players are Proteus Digital Health, Inc.; Fitbit, Inc.; Pear Therapeutics, Inc.; Kaia Health; Happify, Inc.; Medtronic Plc.; Omada Health, Inc.; Livongo Health, Inc.; Voluntis Inc.; Resmed, Inc.; Welldoc, Inc.; 2Morrow Inc.; Canary Health; and Mindable Health GmbH.

Polaris Market Research has segmented the digital therapeutics market report based on revenue model, application, end users, and region:

By Revenue Model Outlook (Revenue - USD billion, 2019-2032)

  • Subscription
  • Value-based
  • One Time Purchase

By Application Outlook (Revenue - USD billion, 2019-2032)

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Lifestyle Management
  • Preventive Applications
  • Others

By End Users Outlook (Revenue - USD billion, 2019-2032)

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

By Regional Outlook (Revenue - USD billion, 2019-2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of the Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Digital Therapeutics Market Insights

  • 4.1. Digital Therapeutics Market - Market Snapshot
  • 4.2. Digital Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Service Oriented Software Are Driving Market Growth
      • 4.2.1.2. Increase in Daily Hours Spend on Internet is Propelling Market Size
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Capital Investment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Digital Therapeutics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Digital Therapeutics Market, by Revenue Model

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
  • 5.3. Subscription
    • 5.3.1. Global Digital Therapeutics Market, by Subscription, by Region, 2019-2032 (USD billion)
  • 5.4. Value Based
    • 5.4.1. Global Digital Therapeutics Market, by Value Based, by Region, 2019-2032 (USD billion)
  • 5.5. One Time Purchase
    • 5.5.1. Global Digital Therapeutics Market, by One Time Purchase, by Region, 2019-2032 (USD billion)

6. Global Digital Therapeutics Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
  • 6.3. Diabetes
    • 6.3.1. Global Digital Therapeutics Market, by Diabetes, by Region, 2019-2032 (USD billion)
  • 6.4. Obesity
    • 6.4.1. Global Digital Therapeutics Market, by Obesity, by Region, 2019-2032 (USD billion)
  • 6.5. CVD
    • 6.5.1. Global Digital Therapeutics Market, by CVD, by Region, 2019-2032 (USD billion)
  • 6.6. CNS Disease
    • 6.6.1. Global Digital Therapeutics Market, by CNS Disease, by Region, 2019-2032 (USD billion)
  • 6.7. Respiratory Disease
    • 6.7.1. Global Digital Therapeutics Market, by CVD, by Respiratory Disease, 2019-2032 (USD billion)
  • 6.8. Smoking Cessation
    • 6.8.1. Global Digital Therapeutics Market, by Smoking Cessation, by Region, 2019-2032 (USD billion)
  • 6.9. Lifestyle Management
    • 6.9.1. Global Digital Therapeutics Market, by Lifestyle Management, by Region, 2019-2032 (USD billion)
  • 6.10. Preventive Applications
    • 6.10.1. Global Digital Therapeutics Market, by Preventive Applications, by Region, 2019-2032 (USD billion)
  • 6.11. Others
    • 6.11.1. Global Digital Therapeutics Market, by Others, by Region, 2019-2032 (USD billion)

7. Global Digital Therapeutics Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 7.3. Patients
    • 7.3.1. Global Digital Therapeutics Market, by Patients, by Region, 2019-2032 (USD billion)
      • 7.3.1.1.
  • 7.4. Providers
    • 7.4.1. Global Digital Therapeutics Market, by Providers, by Region, 2019-2032 (USD billion)
  • 7.5. Payers
    • 7.5.1. Global Digital Therapeutics Market, by Payers, by Region, 2019-2032 (USD billion)
  • 7.6. Employers

Global Digital Therapeutics Market, by Employers, by Region, 2019-2032 (USD billion)

  • 7.7. Others

Global Digital Therapeutics Market, by Others, by Region, 2019-2032 (USD billion)

8. Global Digital Therapeutics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Digital Therapeutics Market Assessment, By Geography, 2019-2032 (USD billion)
  • 8.3. Digital Therapeutics Market - North America
    • 8.3.1. North America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.3.2. North America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.3.3. North America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.3.4. Digital Therapeutics Market - U.S.
      • 8.3.4.1. U.S.: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.3.4.2. U.S.: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.3.4.3. U.S.: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.3.5. Digital Therapeutics Market - Canada
      • 8.3.5.1. Canada: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.3.5.2. Canada: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.3.5.3. Canada: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 8.4. Digital Therapeutics Market - Europe
    • 8.4.1. Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.4.2. Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.4.3. Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.4. Digital Therapeutics Market - UK
      • 8.4.4.1. UK: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.4.2. UK: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.4.3. UK: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.5. Digital Therapeutics Market - France
      • 8.4.5.1. France: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.5.2. France: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.5.3. France: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.6. Digital Therapeutics Market - Germany
      • 8.4.6.1. Germany: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.6.2. Germany: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.6.3. Germany: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.7. Digital Therapeutics Market - Italy
      • 8.4.7.1. Italy: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.7.2. Italy: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.7.3. Italy: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.8. Digital Therapeutics Market - Spain
      • 8.4.8.1. Spain: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.8.2. Spain: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.8.3. Spain: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.9. Digital Therapeutics Market - Netherlands
      • 8.4.9.1. Netherlands: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.9.2. Netherlands: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.9.3. Netherlands: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.10. Digital Therapeutics Market - Russia
      • 8.4.10.1. Russia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.10.2. Russia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.10.3. Russia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.4.11. Digital Therapeutics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.4.11.2. Rest of Europe: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.4.11.3. Rest of Europe: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 8.5. Digital Therapeutics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.5.2. Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.5.3. Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.4. Digital Therapeutics Market - China
      • 8.5.4.1. China: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.4.2. China: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.4.3. China: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.5. Digital Therapeutics Market - India
      • 8.5.5.1. India: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.5.2. India: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.5.3. India: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.6. Digital Therapeutics Market - Malaysia
      • 8.5.6.1. Malaysia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.6.2. Malaysia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.6.3. Malaysia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.7. Digital Therapeutics Market - Japan
      • 8.5.7.1. Japan: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.7.2. Japan: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.7.3. Japan: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.8. Digital Therapeutics Market - Indonesia
      • 8.5.8.1. Indonesia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.8.2. Indonesia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.8.3. Indonesia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.9. Digital Therapeutics Market - South Korea
      • 8.5.9.1. South Korea: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.9.2. South Korea: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.9.3. South Korea: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.10. Digital Therapeutics Market - Australia
      • 8.5.10.1. Australia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.10.2. Australia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.10.3. Australia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.5.11. Digital Therapeutics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.5.11.2. Rest of Asia Pacific: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.5.11.3. Rest of Asia Pacific: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 8.6. Digital Therapeutics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.6.2. Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.6.3. Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.4. Digital Therapeutics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.4.2. Saudi Arabia: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.4.3. Saudi Arabia: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.5. Digital Therapeutics Market - UAE
      • 8.6.5.1. UAE: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.5.2. UAE: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.5.3. UAE: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.6. Digital Therapeutics Market - Israel
      • 8.6.6.1. Israel: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.6.2. Israel: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.6.3. Israel: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.7. Digital Therapeutics Market - South Africa
      • 8.6.7.1. South Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.7.2. South Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.7.3. South Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.6.8. Digital Therapeutics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.6.8.2. Rest of Middle East & Africa: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.6.8.3. Rest of Middle East & Africa: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
  • 8.7. Digital Therapeutics Market - Latin America
    • 8.7.1. Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
    • 8.7.2. Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
    • 8.7.3. Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.7.4. Digital Therapeutics Market - Mexico
      • 8.7.4.1. Mexico: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.7.4.2. Mexico: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.7.4.3. Mexico: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.7.5. Digital Therapeutics Market - Brazil
      • 8.7.5.1. Brazil: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.7.5.2. Brazil: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.7.5.3. Brazil: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.7.6. Digital Therapeutics Market - Argentina
      • 8.7.6.1. Argentina: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.7.6.2. Argentina: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.7.6.3. Argentina: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)
    • 8.7.7. Digital Therapeutics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Digital Therapeutics Market, by Revenue Model, 2019-2032 (USD billion)
      • 8.7.7.2. Rest of Latin America: Digital Therapeutics Market, by Application, 2019-2032 (USD billion)
      • 8.7.7.3. Rest of Latin America: Digital Therapeutics Market, by End User, 2019-2032 (USD billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Proteus Digital Health, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Fitbit Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Pear Therapeutics, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Kaia Health
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Happify, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Medtronic Plc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Omada Health, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Livongo Health, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Voluntis, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Resmed, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Welldoc, Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. 2Morrow Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Canary Health
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Mindable Health GmbH.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development